twenty-one patients with leukemia and lymphoma refractory to conventional therapy were treated with thymidine ( dthd ) at a dose of 75 g/m2/day for 48 h by continuous intravenous ( iv ) infusion , followed by cytosine arabinoside ( ara-c ) on an escalating dose schedule of 25-625 mg/m2/day for 48 h by continuous iv infusion .
C0024299
lymphoma
C0010711
cytosine arabinoside